ResearchMoz

Therapeutic Area Market Research Reports & Industry Analysis

Therapeutic Area Market Research Reports & Industry Analysis Therapeutic Area

Browse reports in Therapeutic Area

Displaying 701 to 730 (of 760 records)
Pages: « Prev  16 17 18 19 20 21 22 23 24 25   Next »
Anemia - Pipeline Assessment and Market Forecasts to 2017
Nov 2010   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Anemia Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Anemia market. The report identifies the key trends shaping and driving the global Anemia market. The report also provides insights on the prevalent competitive landscape and the...
$2000
Systemic Lupus Erythematosus - Pipeline Assessment and Market Forecasts to 2017
Nov 2010   |   By - GlobalData
GlobalData, the industry analysis specialists new report, Systemic Lupus Erythematosus Pipeline Assessment and Market Forecasts to 2017 is an essential source of information and analysis on the global systemic lupus erythematosus market. The report identifies the key trends shaping and driving the global systemic lupus erythematosus market. The report also provides insight on the...
$2000
Growth Hormone Deficiency (GHD) - Pipeline Assessment and Market Forecasts to 2017
Nov 2010   |   By - GlobalData
GlobalDatas report, Growth Hormone Deficiency Pipeline Assessment and Market Forecasts to 2017, is an essential source of information and analysis on the global groeth hormone deficiency (GHD) market. The report identifies the key trends shaping and driving the global GHD market. The report also provides insights into the prevalent competitive landscape and the emerging players expected...
$2000
Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017
Nov 2010   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Peripheral Arterial Disease (PAD) Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global PAD market. The report identifies the key trends shaping and driving the global PAD market. The report also provides insights on the prevalent competitive...
$2000
Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010
Nov 2010   |   By - GlobalData
Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010 Summary GlobalData, the industry analysis specialist, has released its new report, Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010. The report is an essential source of information and analysis on the global colorectal cancer therapeutics market. The report provides...
$5000
Colorectal Cancer - Japan Drug Forecasts and Treatment Analysis to 2020
Nov 2010   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Colorectal Cancer Japan Drug Forecasts and Treatment Analysis to 2020. The report is an essential source of information and analysis on the Japanese colorectal cancer therapeutics market. The report provides comprehensive information on colorectal cancer, highlighting the treatment guidelines. It identifies...
$3000
Colorectal Cancer - Italy Drug Forecasts and Treatment Analysis to 2020
Nov 2010   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Colorectal Cancer Italy Drug Forecasts and Treatment Analysis to 2020. The report is an essential source of information and analysis on the Italian colorectal cancer therapeutics market. The report provides comprehensive information on colorectal cancer, highlighting the treatment guidelines. It identifies and...
$3000
Colorectal Cancer - UK Drug Forecasts and Treatment Analysis to 2020
Nov 2010   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Colorectal Cancer UK Drug Forecasts and Treatment Analysis to 2020. The report is an essential source of information and analysis on the UK colorectal cancer therapeutics market. The report provides comprehensive information on colorectal cancer, highlighting the treatment guidelines. It identifies and analyses the...
$3000
Colorectal Cancer - Spain Drug Forecasts and Treatment Analysis to 2020
Nov 2010   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Colorectal Cancer Spain Drug Forecasts and Treatment Analysis to 2020. The report is an essential source of information and analysis on the Spanish colorectal cancer therapeutics market. The report provides comprehensive information on colorectal cancer, highlighting the treatment guidelines. It identifies and...
$3000
Colorectal Cancer - Germany Drug Forecasts and Treatment Analysis to 2020
Nov 2010   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer Germany Drug Forecasts and Treatment Analysis to 2020”. The report is an essential source of information and analysis on the German colorectal cancer therapeutics market. The report provides comprehensive information on colorectal cancer, highlighting the treatment guidelines. It...
$3000
Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020
Nov 2010   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Colorectal Cancer France Drug Forecasts and Treatment Analysis to 2020. The report is an essential source of information and analysis on the French colorectal cancer therapeutics market. The report provides comprehensive information on colorectal cancer, highlighting the treatment guidelines. It identifies and...
$3000
Colorectal Cancer - US Drug Forecasts and Treatment Analysis to 2020
Nov 2010   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Colorectal Cancer US Drug Forecasts and Treatment Analysis to 2020. The report is an essential source of information and analysis on the US colorectal cancer therapeutics market. The report provides comprehensive information on colorectal cancer, highlighting the treatment guidelines. It identifies and analyses the...
$3000
Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020
Nov 2010   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Colorectal Cancer Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020. The report is an essential source of information and analysis on the colorectal cancer therapeutics market in emerging countries, Brazil, China, India and Russia (BRIC). The report provides comprehensive...
$3000
Chronic Kidney Disease - Pipeline Assessment and Market Forecasts to 2016
Nov 2010   |   By - GlobalData
GlobalData, the industry analysis specialists new report, Chronic Kidney Disease Pipeline Assessment and Market Forecasts to 2016 is an essential source of information and analysis on the global chronic kidney disease market. The report identifies the key trends shaping and driving the global chronic kidney disease market. The report also provides insight on the prevalent competitive...
$2000
Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2017
Oct 2010   |   By - GlobalData
GlobalData, the industry analysis specialists new report, Cancer Vaccines Pipeline Assessment and Market Forecasts to 2017 is an essential source of information and analysis on the global Cancer vaccines market. The report identifies key trends shaping and driving the global Atopic dermatitis disease market. It also provides insight on the prevalent competitive landscape and the emerging...
$2000
Acute Lymphocytic Leukemia (ALL) Clinical Trials Review Q4, 2010
Oct 2010   |   By - GlobalData
GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL) Global Clinical Trials Review, Q4, 2010""” provides data on the Acute Lymphocytic Leukemia (ALL) clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Acute Lymphocytic Leukemia (ALL). It includes an overview of the trial numbers and their...
$1000
Acute Myelogenous Leukemia Global Clinical Trials Review, Q4, 2010
Oct 2010   |   By - GlobalData
GlobalData's clinical trial report, “ Acute Myelocytic Leukemia (AML)Global Clinical Trials Review, Q4, 2010""” provides data on the Acute Myelocytic Leukemia (AML)clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Acute Myelocytic Leukemia (AML). It includes an overview of the trial numbers and their...
$1000
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trial Review, Q4, 2010
Oct 2010   |   By - GlobalData
GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, Q4, 2010"" provides data on the Chronic Lymphocytic Leukemia (CLL) clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). It includes an overview of the trial numbers and their...
$1000
Chronic Myelocytic Leukemia(CML) Global Clinical Trial Review, Q4, 2010
Oct 2010   |   By - GlobalData
GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, Q4, 2010"" provides data on the Chronic Myelocytic Leukemia (CML) clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Chronic Myelocytic Leukemia (CML). It includes an overview of the trial numbers and their...
$1000
Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis and Psoriatic Arthritis
Oct 2010   |   By - GBI Research
GBI Research’s new report, “Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global hepatitis therapeutics market.. Treatment usage patterns, sales, prices and volumes are forecast until 2016 for the key...
$3500
Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
Oct 2010   |   By - GBI Research
GBI Research’s report, “Musculoskeletal Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First-in-class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis, provides in-depth analysis of unmet needs, drivers and barriers that impact the global musculoskeletal disorders market. The report analyzes the markets for...
$3500
Meningitis Preventive Vaccines - Pipeline Analysis and Market Forecasts to 2017
Oct 2010   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Meningitis Preventive Vaccines Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Meningitis Preventive Vaccines market. The report identifies the key trends shaping and driving the global Meningitis Preventive Vaccines market. The report...
$2000
Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017
Oct 2010   |   By - GlobalData
GlobalData, the industry analysis specialists new report, Head and Neck Cancer Pipeline Assessment and Market Forecast to 2017 is an essential source of information and analysis on the global head and neck cancer market. The report identifies the key trends shaping and driving the global head and neck cancer market. The report also provides insight on the prevalent competitive landscape...
$2000
Colorectal Cancer - Pipeline Assessment and Market Forecasts to 2020
Oct 2010   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Colorectal Cancer Pipeline Assessment and Market Forecasts to 2020. The report is an essential source of information and analysis on the global Colorectal Cancer therapeutics market. The report identifies the key trends shaping and driving the global Colorectal Cancer therapeutics market. The report also provides...
$3500
Stomach Cancer - Pipeline Assessment and Market Forecasts to 2017
Oct 2010   |   By - GlobalData
GlobalDatas report, Stomach Cancer Pipeline Assessment and Market Forecasts to 2017, is an essential source of information and analysis on the global stomach cancer market. The report identifies the key trends shaping and driving the global stomach cancer market. The report also provides insights into the prevalent competitive landscape and the emerging players expected to alter the...
$2000
Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017
Sep 2010   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Influenza Vaccines Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Influenza Vaccines market. The report identifies the key trends shaping and driving the global Influenza Vaccines market. The report also provides insights into the...
$2000
Osteoporosis - Pipeline Assessment and Market Forecasts to 2017
Sep 2010   |   By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Osteoporosis - Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Osteoporosis therapeutics market. The report identifies the key trends shaping and driving the global Osteoporosis therapeutics market. The report also provides insights into the...
$2000
Acute Myeloid Leukemia (AML) - Pipeline Assessment and Market Forecasts to 2017
Sep 2010   |   By - GlobalData
GlobalData has released its pharmaceutical report, Acute Myeloid Leukemia (AML) Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global AML therapeutics market. The report identifies the key trends shaping and driving the global AML therapeutics market. The report also provides insights on the prevalent competitive...
$2000
Epigenetics Therapeutics to 2017 High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma
Sep 2010   |   By - GBI Research
GBI Researchs report, Epigenetics Therapeutics to 2017 High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the technology that shape the industry dynamics for the key geographies: the US, the top five countries in Europe (the UK,...
$3500
Hepatitis Therapeutics Market to 2016 - Strong Hepatitis-C Pipeline and Cost Effective Treatments will Drive the Global Hepatitis Market
Sep 2010   |   By - GBI Research
GBI Research’s pharmaceuticals report, “Hepatitis Therapeutics Market to 2016 - Strong Hepatitis-C Pipeline and Cost Effective Treatments will Drive the Global Hepatitis Market”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global hepatitis therapeutics market. The report analyzes the markets for hepatitis therapeutics in the US,...
$3500
 
Displaying 701 to 730 (of 760 records)
Pages: « Prev  16 17 18 19 20 21 22 23 24 25   Next »